Brought to you by 
Perrigo buys Agis Industries for $881mm in cash and stock
03 Dec 2004
Executive Summary
To build a leading diversified healthcare firm, Perrigo Co. (OTC drugs and nutritional products) is acquiring Israeli generic pharmaceutical company Agis Industries Ltd. for a total of $881mm--$443mm in cash and $438mm in stock, a 26% premium over Agis's market average. Perrigo will also assume $15mm in Agis outstanding debt.
Deal Industry
- In Vitro Diagnostics
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
- OTC, Consumer
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Perrigo buys Agis Industries for $881mm in cash and stock
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice